Back to Search
Start Over
Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis
- Source :
- BMC Gastroenterology, Vol 20, Iss 1, Pp 1-9 (2020), BMC Gastroenterology
- Publication Year :
- 2020
- Publisher :
- BMC, 2020.
-
Abstract
- Background Hyperuricemia is a major risk for non-alcoholic fatty liver disease. However, the mechanisms for this phenomenon are not fully understood. This study aimed to investigate whether microRNAs mediated the pathogenic effects of uric acid on non-alcoholic fatty liver disease. Methods Microarray was used to determine the hepatic miRNA expression profiles of male C57BL/6 mice fed on standard chow diet, high fat diet (HFD), and HFD combined with uric acid-lowering therapy by allopurinol. We validated the expression of the most significant differentially expressed microRNAs and explored its role and downstream target in uric acid-induced hepatocytes lipid accumulation. Results Microarray analysis and subsequent validation showed that miR-149-5p was significantly up-regulated in the livers of HFD-fed mice, while the expression was down-regulated by allopurinol therapy. MiR-149-5p expression was also significantly up-regulated in uric acid-stimulated hepatocytes. Over-expression of miR-149-5p significantly aggregated uric acid-induced triglyceride accumulation in hepatocytes, while inhibiting miR-149-5p ameliorated the triglyceride accumulation. Luciferase report assay confirmed that FGF21 is a target gene of miR-149-5p. Silencing FGF21 abolished the ameliorative effects of miR-149-5p inhibitor on uric acid-induced hepatocytes lipid accumulation, while overexpression of FGF21 prevented the lipid accumulation induced by miR-149-5p mimics. Conclusions Uric acid significantly up-regulated the expression of miR-149-5p in hepatocytes and induced hepatocytes lipid accumulation via regulation of miR-149-5p/FGF21 axis.
- Subjects :
- 0301 basic medicine
Male
medicine.medical_specialty
Xanthine Oxidase
FGF21
Antimetabolites
Allopurinol
Hyperuricemia
Diet, High-Fat
03 medical and health sciences
chemistry.chemical_compound
Mice
0302 clinical medicine
Internal medicine
Medicine
Gene silencing
Animals
Enzyme Inhibitors
lcsh:RC799-869
Triglycerides
Triglyceride
business.industry
Microarray analysis techniques
Fatty liver
Gastroenterology
nutritional and metabolic diseases
General Medicine
medicine.disease
miR-149-5p
Up-Regulation
Fibroblast Growth Factors
Mice, Inbred C57BL
MicroRNAs
030104 developmental biology
Endocrinology
chemistry
Hepatocytes
Uric acid
030211 gastroenterology & hepatology
lcsh:Diseases of the digestive system. Gastroenterology
business
medicine.drug
Research Article
Non-alcoholic fatty liver disease
Subjects
Details
- Language :
- English
- Volume :
- 20
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- BMC Gastroenterology
- Accession number :
- edsair.doi.dedup.....b4925fd2807307c9e5d291961d9d319f